[
    {
        "contents": "data\\APS\\20161221-222316.news",
        "description": null,
        "guid": "yahoo_finance/1146342254",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/aptose-biosciences-reports-3q-loss-005147522.html",
        "pubDate": "Tue, 15 Nov 2016 00:51:47 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences reports 3Q loss"
    },
    {
        "contents": "data\\APS\\20161221-222317.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/2133117944",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128oj7lbe/*http://www.publicnow.com/view/C36A204D6C915E50D837484F85353930B9CCAECD",
        "pubDate": "Tue, 15 Nov 2016 00:37:07 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222318.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 14, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...",
        "guid": "yahoo_finance/61283263",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-reports-financial-results-002226920.html",
        "pubDate": "Tue, 15 Nov 2016 00:22:26 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222320.news",
        "description": null,
        "guid": "yahoo_finance/873914653",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20161114.html?t=aps.to",
        "pubDate": "Mon, 14 Nov 2016 12:07:02 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Q3 2016 Aptose Biosciences Inc Earnings Release - After Market Close"
    },
    {
        "contents": "data\\APS\\20161221-222320.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target ...",
        "guid": "yahoo_finance/779292158",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286c2ufe/*http://www.publicnow.com/view/60916A4830A8D1B29F985DABFABE98BF6CD22A4B",
        "pubDate": "Thu, 10 Nov 2016 12:11:05 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222320.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 10, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, will release ...",
        "guid": "yahoo_finance/2224949520",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-release-third-quarter-ended-120000945.html",
        "pubDate": "Thu, 10 Nov 2016 12:00:00 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222321.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Nov. 03, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...",
        "guid": "yahoo_finance/806159498",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-present-apto-253-data-201500154.html",
        "pubDate": "Thu, 03 Nov 2016 20:15:00 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting"
    },
    {
        "contents": "data\\APS\\20161221-222323.news",
        "description": null,
        "guid": "yahoo_finance/2476011472",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/9/154239.html",
        "pubDate": "Thu, 13 Oct 2016 12:30:00 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Inc Conference Call to Discuss on FDA Clinical Hold of APTO-253 scheduled for 8:30 am ET today"
    },
    {
        "contents": "data\\APS\\20161221-222323.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/3795445095",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128fa26k0/*http://www.publicnow.com/view/146BC11F3B946AA3089AF89794789D264AC1A852",
        "pubDate": "Thu, 13 Oct 2016 11:10:03 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Provides Update on FDA Clinical Hold of APTO-253"
    },
    {
        "contents": "data\\APS\\20161221-222323.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Oct. 13, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...",
        "guid": "yahoo_finance/1096424855",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-provides-fda-clinical-hold-110000845.html",
        "pubDate": "Thu, 13 Oct 2016 11:00:00 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Provides Update on FDA Clinical Hold of APTO-253"
    },
    {
        "contents": "data\\APS\\20161221-222326.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/2564577075",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1285edpnh/*http://www.publicnow.com/view/6B5FBAC4B989432BC1690DC967798F0100EE30F3",
        "pubDate": "Mon, 12 Sep 2016 12:18:07 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Submits Formal Response to Clinical Hold for APTO-253"
    },
    {
        "contents": "data\\APS\\20161221-222326.news",
        "description": null,
        "guid": "yahoo_finance/3838680138",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/edited-transcript-aps-earnings-conference-164855529.html",
        "pubDate": "Wed, 17 Aug 2016 16:48:55 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Edited Transcript of APS.TO earnings conference call or presentation 9-Aug-16 9:00pm GMT"
    },
    {
        "contents": "data\\APS\\20161221-222327.news",
        "description": null,
        "guid": "yahoo_finance/3971095626",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://sg.finance.yahoo.com/news/aptose-biosciences-reports-2q-loss-235145229.html",
        "pubDate": "Tue, 09 Aug 2016 23:51:45 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences reports 2Q loss"
    },
    {
        "contents": "data\\APS\\20161221-222329.news",
        "description": null,
        "guid": "yahoo_finance/2170877566",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-reports-2q-loss-235145375.html",
        "pubDate": "Tue, 09 Aug 2016 23:51:45 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences reports 2Q loss"
    },
    {
        "contents": "data\\APS\\20161221-222331.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/3214387815",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128u8kn1b/*http://www.publicnow.com/view/4C1DB4657C803F0BF45A279F10C5341346031684",
        "pubDate": "Tue, 09 Aug 2016 20:30:10 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Reports Financial Results for the Second Quarter Ended June 30, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222331.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target ...",
        "guid": "yahoo_finance/303145257",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128fc6ogf/*http://www.publicnow.com/view/52042A99D854A3FA022D9B36720D96763C85A920",
        "pubDate": "Thu, 04 Aug 2016 20:44:13 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose To Release Second Quarter Ended June 30, 2016 Financial Results and Hold Conference Call on August 9, 2016"
    },
    {
        "contents": "data\\APS\\20161221-222331.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, June 21, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) ('Aptose' or the 'Company') today announced the voting results from the Company's annual meeting ...",
        "guid": "yahoo_finance/1727704490",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1286dau70/*http://www.publicnow.com/view/7024805C4E3223349786EC9067DCBF7A85F37518",
        "pubDate": "Tue, 21 Jun 2016 20:19:01 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Announces Results of Annual Meeting of Shareholders"
    },
    {
        "contents": "data\\APS\\20161221-222331.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, June 21, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) ('Aptose' or the 'Company') today provided a corporate update in advance of the Company's Annual ...",
        "guid": "yahoo_finance/4191170161",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128lav2hq/*http://www.publicnow.com/view/8220CC97CE42DDF8032A21C4D63CDCF1ABA03956",
        "pubDate": "Tue, 21 Jun 2016 12:39:04 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences Provides Corporate Update in Advance of Annual Meeting of Shareholders"
    },
    {
        "contents": "data\\APS\\20161221-222331.news",
        "description": "[at noodls] - TORONTO and SEOUL, South Korea, June 08, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) and CrystalGenomics, Inc. (KOSDAQ:083790) today announced an exclusive global option and ...",
        "guid": "yahoo_finance/2281936566",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128nfgr65/*http://www.publicnow.com/view/FCF572A8873D801535618FA6F0DC877B7A7486FF",
        "pubDate": "Wed, 08 Jun 2016 12:18:05 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Aptose Biosciences and CrystalGenomics Announce Exclusive Agreement for Non-Covalent BTK / FLT3 / AURK Inhibitor"
    },
    {
        "contents": "data\\APS\\20161221-222332.news",
        "description": null,
        "guid": "yahoo_finance/258270812",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/edited-transcript-aps-earnings-conference-162058706.html",
        "pubDate": "Wed, 11 May 2016 16:20:58 GMT",
        "source": "data\\APS\\20161221.rss",
        "title": "Edited Transcript of APS.TO earnings conference call or presentation 10-May-16 9:00pm GMT"
    },
    {
        "contents": "data\\APS\\20161229-090133.news",
        "description": null,
        "guid": "yahoo_finance/3243267234",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-aps-131500725.html",
        "pubDate": "Thu, 29 Dec 2016 13:15:00 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "IIROC Trade Resumption - APS"
    },
    {
        "contents": "data\\APS\\20161229-090135.news",
        "description": null,
        "guid": "yahoo_finance/2360291799",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trade-resumption-aps-131500177.html",
        "pubDate": "Thu, 29 Dec 2016 13:15:00 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "IIROC Trade Resumption - APS"
    },
    {
        "contents": "data\\APS\\20161229-090137.news",
        "description": null,
        "guid": "yahoo_finance/2094534205",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-aps-131300858.html",
        "pubDate": "Thu, 29 Dec 2016 13:13:00 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "IIROC Trading Halt - APS"
    },
    {
        "contents": "data\\APS\\20161229-090138.news",
        "description": null,
        "guid": "yahoo_finance/675417445",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/iiroc-trading-halt-aps-131300757.html",
        "pubDate": "Thu, 29 Dec 2016 13:13:00 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "IIROC Trading Halt - APS"
    },
    {
        "contents": "data\\APS\\20161229-090140.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, Dec. 29, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/1100804183",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1288r4amj/*http://www.publicnow.com/view/8A18673E1ABB702102DDA568BF712F4A7207A6CC",
        "pubDate": "Thu, 29 Dec 2016 13:12:08 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "Aptose Biosciences Provides Update on APTO-253 Development"
    },
    {
        "contents": "data\\APS\\20161229-090140.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Dec. 29, 2016-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today provided ...",
        "guid": "yahoo_finance/3642804434",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-provides-apto-253-130000215.html",
        "pubDate": "Thu, 29 Dec 2016 13:00:00 GMT",
        "source": "data\\APS\\20161229.rss",
        "title": "Aptose Biosciences Provides Update on APTO-253 Development"
    },
    {
        "contents": "data\\APS\\20170106-212135.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Jan. 05, 2017-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...",
        "guid": "yahoo_finance/3188921028",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-present-biotech-showcase-130000176.html",
        "pubDate": "Thu, 05 Jan 2017 13:00:00 GMT",
        "source": "data\\APS\\20170106.rss",
        "title": "Aptose Biosciences to Present at Biotech Showcase 2017 Conference"
    },
    {
        "contents": "data\\APS\\20170110-090118.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, May 10, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying ...",
        "guid": "yahoo_finance/4187030077",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128eh6tdg/*http://www.publicnow.com/view/C1BD8CC446E583B6560C93F898340768A8398A03",
        "pubDate": "Tue, 10 May 2016 20:28:10 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Aptose Bioscience Reports Results for the First Quarter Ended March 31, 2016"
    },
    {
        "contents": "data\\APS\\20170110-090118.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, May 02, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target ...",
        "guid": "yahoo_finance/2085718217",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128u6i36f/*http://www.publicnow.com/view/BC9A2F8D379337BB88084F6B6DE230820E74F579",
        "pubDate": "Mon, 02 May 2016 12:20:03 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Aptose To Release First Quarter Ended March 31, 2016 Financial Results and Hold Conference Call on May 10, 2016"
    },
    {
        "contents": "data\\APS\\20170110-090118.news",
        "description": null,
        "guid": "yahoo_finance/1389964646",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/edited-transcript-aps-earnings-conference-193736424.html",
        "pubDate": "Wed, 30 Mar 2016 19:37:36 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Edited Transcript of APS.TO earnings conference call or presentation 29-Mar-16 9:00pm GMT"
    },
    {
        "contents": "data\\APS\\20170110-090120.news",
        "description": "[at noodls] - SAN DIEGO and TORONTO, March 29, 2016 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) a clinical-stage company developing new therapeutics and molecular diagnostics that target the ...",
        "guid": "yahoo_finance/3873261225",
        "link": "http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=128opbeps/*http://www.publicnow.com/view/10617091D8ED24DC8A54C16CB874B640B9470E64",
        "pubDate": "Tue, 29 Mar 2016 20:36:15 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Aptose Reports Fourth Quarter and Year End 2015 Results"
    },
    {
        "contents": "data\\APS\\20170110-090120.news",
        "description": null,
        "guid": "yahoo_finance/1259842115",
        "link": "http://us.rd.yahoo.com/finance/external/xinsidermonkey/rss/SIG=12okukra3/*http://www.insidermonkey.com/blog/should-you-stay-away-from-fx-energy-inc-fxen-401184/",
        "pubDate": "Wed, 09 Dec 2015 03:48:00 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Should You Stay Away From FX Energy, Inc. (FXEN)?"
    },
    {
        "contents": "data\\APS\\20170110-090121.news",
        "description": null,
        "guid": "yahoo_finance/2282522178",
        "link": "http://us.rd.yahoo.com/finance/external/xinsidermonkey/rss/SIG=12m8m64kc/*http://www.insidermonkey.com/blog/should-you-buy-aptose-biosciences-inc-apto-394547/",
        "pubDate": "Mon, 30 Nov 2015 15:44:34 GMT",
        "source": "data\\APS\\20170110.rss",
        "title": "Should You Buy Aptose Biosciences Inc (APTO)?"
    },
    {
        "contents": "data\\APS\\20170123-091117.news",
        "description": "[GlobeNewswire] - Pauses APTO-253 to Elucidate Manufacturing Setback. --Company to Host Conference Call Today at 8:30 AM ET--. SAN DIEGO and TORONTO, Jan. 23, 2017-- Aptose Biosciences Inc., a clinical-stage company developing ...",
        "guid": "yahoo_finance/3194694268",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-prioritizes-development-cg-806-120000032.html",
        "pubDate": "Mon, 23 Jan 2017 12:00:00 GMT",
        "source": "data\\APS\\20170123.rss",
        "title": "Aptose Prioritizes Development of CG\u2019806 First-in Class FLT3/BTK Inhibitor"
    },
    {
        "contents": "data\\APS\\20170202-090934.news",
        "description": "[GlobeNewswire] - SAN DIEGO and TORONTO, Feb. 02, 2017-- Aptose Biosciences Inc., a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer, today announced ...",
        "guid": "yahoo_finance/3336915360",
        "link": "http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/aptose-biosciences-present-canaccord-genuity-120000698.html",
        "pubDate": "Thu, 02 Feb 2017 12:00:00 GMT",
        "source": "data\\APS\\20170202.rss",
        "title": "Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day"
    }
]